Proof-of-concept study of a web-based methotrexate decision aid for patients with rheumatoid arthritis

Arthritis Care and Research

Volumn 66, Issue 10, 2014, Pages 1472-1481

  Li, Linda C ^a   Adam, Paul M ^b   Backman, Catherine L ^a   Lineker, Sydney ^c   Jones, C Allyson ^d   Lacaille, Diane ^a   Townsend, Anne F ^a   Yacyshyn, Elaine ^d   Yousefi, Charlene ^a   Tugwell, Peter ^e   Leese, Jenny ^a   Stacey, Dawn ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

^c Arthritis Society   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFLICT; CONSUMER; DISEASE DURATION; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNET; INTERVIEW; LIFESTYLE MODIFICATION; MALE; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; RHEUMATOID ARTHRITIS; SELF CARE; AGED; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; DECISION SUPPORT SYSTEM; EVALUATION STUDY; MIDDLE AGED; PATIENT; PATIENT ATTITUDE; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CONFLICT (PSYCHOLOGY); DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; MALE; METHOTREXATE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENTS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84903726619     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22319     Document Type: Article

References (50)

1. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of diseasemodifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39.
2. Suarez-Almazor ME, Belseck E, Shea BJ, Tugwell P, Wells G. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 2008;3:CD002047.
3. Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, et al. Leflunomide for treating rheumatoid arthritis. Cochrane Database Syst Rev 2008;3:CD000957.
4. Suarez-Almazor M, Osiri M, Emery P, and the Ottawa Methods Group. Rheumatoid arthritis. In: Tugwell P, Shea B, Boers M, Brooks P, Simon LS, Strand V, et al, editors. Evidencebased rheumatology. London: BMJ Books; 2003. p. 287-94.
5. Sokka T, Mottonen T, Hannonen P. Disease-modifying antirheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature. Rheumatology (Oxford) 2000;39:34-42.
6. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 1996;39:616-22.
7. Abu-Shakra M, Toker R, Flusser D, Flusser G, Friger M, Sukenik S, et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifyingdrugs. Arthritis Rheum 1998;41:1190-5.
8. Munro R, Hampson R, McEntegart A, Thomson EA, Madhok R, Capell HA. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis 1998; 57:88-93.
9. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the Hydroxychloroquine in Early Rheumatoid Arthritis (HERA) Study. J Rheumatol 2000;27:623-9.
10. Van der Heide A, Jacobs JW, Bijlsma JW, Hcurkens AH, Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with second-line antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996;124:699-707.
11. Lard LR, Visser H, Speyer I, van der Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
12. Buckland-Wright J. Quantitative microfocal radiography detects changes in erosion area in patients with early RA treated with myochrisine. J Rheumatol 1993;20:243-7.
13. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
14. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Honen J, et al, for the FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using singledrug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46:894-8.
15. Shipton D, Glazier RH, Guan J, Badley EM, Shipton D, Glazier RH, et al. Effects of use of specialty services on diseasemodifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 2004;42:907-13.
16. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241-8.
17. Widdifield J, Bernatsky S, Paterson JM, Thorne JC, Cividino A, Pope J, et al. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective. Arthritis Care Res (Hoboken) 2011;63:53-7.
18. Lacaille D, Rogers P. Why are people with rheumatoid arthritis not using DMARDs? Understanding gaps in care [abstract]. Arthritis Rheum 2007;56 Suppl:S86.
19. Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 2003;327:837.
20. Kay EA, Punchak SS. Patient understanding of the causes and medical treatment of rheumatoid arthritis. Rheumatology (Oxford) 1988;27:396-8.
21. Carder PC, Vuckovic N, Green CA. Negotiating medications: patient perceptions of long-term medication use. J Clin Pharm Ther 2003;28:409-17.
22. Townsend AF, Backman CL, Adam P, Li LC. A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early post diagnosis. BMJ Open 2013;3:e002164.
23. Ottawa Health Research Institute. International Patient Decision Aid Standards (IPDAS) checklist. 2008. URL: http://decisionaid.ohri.ca/methods.html#checklist.
24. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417.
25. O'Connor AM, Graham ID, Visser A. Implementing shared decision making in diverse health care systems: the role of patient decision aids. Patient Educ Couns 2005;57:247-9.
26. Legare F, Stacey D, Forest PG. Shared decision-making in Canada: update, challenges and where next! Z Arztl Fortbild Qualitatssich 2007;101:213-21.
27. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 1998;33:267-79.
28. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;2:CD001431.
29. Cochrane Musculoskeletal Group. Decision aids. 2011. URL: http://musculoskeletal.cochrane.org/decision-aids.
30. Fraenkel L, Peters E, Charpentier PA, Olsen B, Errante L, Schoen RT, et al. Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64:977-85.
31. Legare F, Ratte S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions. Patient Educ Couns 2008;73:526-35.
32. Elwyn G, O'Connor AM, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417.
33. Li LC, Adam PM, Townsend AF, Lacaille D, Yousefi C, Stacey D, et al. Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis. BMC Med Inform Decis Mak 2013;13:131.
34. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086-93.
35. Stacey D, Murray MA, Legare F, Sandy D, Menard P, O'Connor A. Decision coaching to support shared decision making: a framework, evidence, and implications for nursing practice, education, and policy. Worldviews Evid Based Nurs 2008;5:25-35.
36. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011;10:CD001431.
37. O'Connor A. User manual: Decisional Conflict Scale. Ottawa: Ottawa Health Research Institute; 2005. URL: http://decisionaid.ohri.ca/docs/develop/User-Manuals/UM-Decisional-Conflict.pdf.
38. Drake ER, Engler-Todd L, O'Connor AM, Surh LC, Alasdair H. Development and evaluation of a decision aid about prenatal testing for women of advanced maternal age. J Genet Couns 1999;8:217-33.
39. Ciciriello S, Wicks IP, Osborne RH, Buchbinder R. Development and validation of the methotrexate in rheumatoid arthritis knowledge test (MiRAKTM). Intern Med J 2010;40 Suppl:9.
40. Ciciriello S, Buchbinder R, Osborne RH, Wicks IP. Improving treatment with methotrexate in rheumatoid arthritis: development of a multimedia patient education program and the MiRAK, a new instrument to evaluate methotrexate-related knowledge. Semin Arthritis Rheum 2014;43:437-46.
41. Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, O'Connor AM, et al. Attributes and skills of an effective musculoskeletal consumer. J Rheumatol 2005;32:2257-61.
42. Tugwell PS, Santesso NA, O'Connor AM, Wilson AJ, and the Effective Consumer Investigative Group. Knowledge translation for effective consumers. Phys Ther 2007;87:1728-38.
43. Kristjansson E, Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, et al. Development of the effective musculoskeletal consumer scale. J Rheumatol 2007;34:1392-400.
44. Lincoln Y, Guba E. Naturalistic inquiry. Beverly Hills: Sage; 1985.
45. Frankel L, Bogardus S, Concato J, Felson D. Preference for disclosure of information among patients with rheumatoid arthritis. Arthritis Care Res 2001;45:136-9.
46. Townsend A, Wyke S, Hunt K. Self-managing and managing self: practical and moral dilemmas in accounts of living with chronic illness. Chronic Illn 2006;2:185-94.
47. Li LC, Townsend AF, Badley EM. Self-management interventions in the digital age: new approaches to support people with rheumatologic conditions. Best Pract Res Clin Rheumatol 2012;26:321-33.
48. Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof 2006;26:13-24.
49. Schkade DA, Kleinmuntz DN. Information displays and choice processes: differential effects of organization, form, and sequence. Organ Behav Hum Decis Process 1994;57:319-37.
50. Lohse GL. Consumer eye movement patterns on yellow pages advertising. J Advert 1997;26:61-73.